Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/21/2012CN101648902B Dihydropyridine type tumor chemotherapeutic sensitizer and application thereof
11/21/2012CN101637462B Compositions for conjugated estrogens and associated methods
11/21/2012CN101624332B New compound with anti-tumor activity and application thereof
11/21/2012CN101621990B Orally administrable films
11/21/2012CN101612290B Medicinal composition for treating burn and scald and preparation method thereof
11/21/2012CN101610764B Benzamide derivatives as EP4 receptor agonists
11/21/2012CN101606921B Acarbose solid sustained-release preparation and preparing method thereof
11/21/2012CN101602708B Aryl alkanol piperidine derivative and application thereof as antidepressive medicine
11/21/2012CN101569622B Pharmaceutical preparation for injection administration and preparation method thereof
11/21/2012CN101557810B Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
11/21/2012CN101548978B Pharmaceutical composition containing alendronate sodium
11/21/2012CN101548959B Coated tablet containing desloratadine and preparation method thereof
11/21/2012CN101543525B Beauty composition containing vaccinium vitis-idaea extract and application thereof
11/21/2012CN101535329B Derivatives of 5-thioxylopyranose and use of same for treatment
11/21/2012CN101518558B Artemisia extract containing high content of eupatilin
11/21/2012CN101511355B Application of (2Z)-2-(3, 4-dihydroxy bezilidene)-1-benzofuran-3(2H)-ketone for preparation of anti-cancer medicine
11/21/2012CN101484444B Novel pyridazine compound and use thereof
11/21/2012CN101484443B Potentiator of radiation therapy
11/21/2012CN101484151B Bivalent smac mimetics and the uses thereof
11/21/2012CN101475617B Refining method for gardenin for injection
11/21/2012CN101466373B A suspension comprising benzimidazole carbamate and a polysorbate
11/21/2012CN101432280B Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
11/21/2012CN101422425B Etretinate type medicine solid dispersion
11/21/2012CN101407531B Use of dimer hydrolysable tannins derivative in preparing medicament and diet additive for treating obesity
11/21/2012CN101365423B Sustained release small molecule drug formulation
11/21/2012CN101346366B Benzochromene derivatives
11/21/2012CN101304769B Acute treatment of social phobia
11/21/2012CN101302199B Guidemycin and use thereof in tumor treatment
11/21/2012CN101245083B Platinum complex containing 1,3-dioxolane structure, synthesizing process and uses thereof
11/21/2012CN101229169B Sustained release formulations comprising lamotrigine
11/21/2012CN101203214B Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
11/21/2012CN101175406B Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
11/21/2012CN101163490B Artificial cerebrospinal fluid
11/21/2012CN101137382B Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
11/21/2012CN101128452B Novel benzoimidazole derivatives and a pharmaceutical composition comprising the same
11/21/2012CN101088502B Mixture solution containing conjugate of transferrin and quercetin and use thereof
11/21/2012CN101039663B STAT3 phosphorylation inhibitor and notch 1 expression inhibitor
11/21/2012CN101018783B Quinoxaline inhibitors of the HEDGEHOG signalling pathway
11/21/2012CN101003556B Derivative of 10 - hydroxyl camptothecin, prepartion of liposome thereof, and preparation method
11/20/2012US8314270 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11/20/2012US8314262 Inhibitors of yeast filamentous growth and method of their manufacture
11/20/2012US8314257 Treatment of CRTH2-mediated diseases and conditions
11/20/2012US8314256 Modulators of ATP-binding cassette transporters
11/20/2012US8314253 Bridged tetrahydronaphthalene derivatives
11/20/2012US8314250 Sultam derivatives
11/20/2012US8314247 Hydrazone derivative
11/20/2012US8314240 Sulfonamide compounds or salts thereof
11/20/2012US8314238 Process for the preparation of an enantiomeric trisubstituted 3,4-dihydro-isoquinoline derivative
11/20/2012US8314234 Bicyclic pyrimidine kinase inhibitors
11/20/2012US8314230 Cyclodextrin-based polymers for therapeutics delivery
11/20/2012US8314221 Pharmacodiagnostic test targeting oncology and neurodegeneration
11/20/2012US8314217 Cross-linked glycopeptide-cephalosporin antibiotics
11/20/2012US8314156 Compositions and methods of delivery of pharmacological agents
11/20/2012US8314154 Topical skin care formulations
11/20/2012US8314153 Treatment of pervasive developmental disorders with redox-active therapeutics
11/20/2012US8314152 Methods and compositions for treating ophthalmic conditions with retinyl derivatives
11/20/2012US8314151 Sphingosine kinase type 1 inhibitors, and processes for using same
11/20/2012US8314150 Kinase protein binding inhibitors
11/20/2012US8314149 Protective role of semapimod in necrotizing enterocolitis
11/20/2012US8314147 Benzamide derivatives as EP4 receptor agonists
11/20/2012US8314146 Thioamide compounds, method of making and method of using thereof
11/20/2012US8314145 High purity 17α-cyanomethyl-17β-hydroxy-estra-4,9-diene-3-one and process for the synthesis thereof
11/20/2012US8314144 Compounds having antitumor activity
11/20/2012US8314143 Synthetic flavonoids and pharmaceutical compositions and therapeutic methods of treatment of HIV infection and other pathologies
11/20/2012US8314142 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
11/20/2012US8314141 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
11/20/2012US8314140 4-hydroxythiobenzamide derivatives of drugs
11/20/2012US8314139 Toluene sulfonic acid salt of a therapeutic compound and pharmaceutical compositions thereof
11/20/2012US8314138 Pyrazole derivative as SCD1 inhibitors for the treatment of diabetes
11/20/2012US8314137 Monocyclic cyanoenones and methods of use thereof
11/20/2012US8314136 Method for treatment of alzheimer's disease and autism spectrum disorders
11/20/2012US8314135 Linked dibenzimidazole antivirals
11/20/2012US8314134 Compounds for inflammation and immune-related uses
11/20/2012US8314133 Process for preparing chiral 3-triazolyl sulphoxide derivatives
11/20/2012US8314132 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of Hsp90 chaperone and the intermediates for production thereof
11/20/2012US8314131 Triazole fused heteroaryl compounds and methods of use thereof
11/20/2012US8314130 Compounds inclunding substituted pyridines for inflammation and immune-related uses
11/20/2012US8314129 Optical isomers of an iloperidone metabolite
11/20/2012US8314127 Piperidine derivatives
11/20/2012US8314126 Disubstituted phenylpiperdines/piperazines as modulators of dopamine neurotransmission
11/20/2012US8314125 Bicyclic derivatives as modulators of ion channels
11/20/2012US8314124 Crystalline salts of quinoline compounds and methods for preparing them
11/20/2012US8314123 5, 6, or 7-substituted -3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof
11/20/2012US8314121 Imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular CDC7
11/20/2012US8314120 Small molecule potentiators of metabotropic glutamate receptors
11/20/2012US8314119 Azaadamantane derivatives and methods of use
11/20/2012US8314118 Methods and compositions for treating dry eye
11/20/2012US8314117 CGRP receptor antagonists
11/20/2012US8314116 2-S-benzyl substituted pyrimidines as CRTH2 antagonists
11/20/2012US8314115 Method of treating movement disorders using barbituric acid derivatives
11/20/2012US8314114 Tricyclic compounds having cytostatic and/or cytoxic activity and methods of use thereof
11/20/2012US8314113 Substituted dihydroquinazolines II
11/20/2012US8314112 Pyrrolopyrimidines and pyrrolopyridines
11/20/2012US8314111 Fused bicyclic motor inhibitors
11/20/2012US8314110 Compounds for treating mental disorders, and preparation and uses thereof
11/20/2012US8314109 6-heterocyclic-imidazo[1,2-α]pyridine-2-carboxamide derivatives, preparation and therapeutic use thereof
11/20/2012US8314108 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile, pharmaceutically acceptable salts thereof, or solvate of salts
11/20/2012US8314107 Carboxamide compounds and methods for using the same
11/20/2012US8314106 Substituted diketopiperazine analogs for use as drug delivery agents
11/20/2012US8314105 Methods of reducing risk of infection from pathogens
1 ... 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 ... 7860